Evidence map›Paper›PMID 27701424›Full record

ArticlePLoS genetics2016

Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis.

Martha C Castaño-Betancourt, Dan S Evans, Yolande F M Ramos, Cindy G Boer, Sarah Metrustry, Youfang Liu, Wouter den Hollander, Jeroen van Rooij, Virginia B Kraus, Michelle S Yau and 27 more

Abstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Regulation of Skeletal Development and Maintenance by Runx2 and Sp7.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Activating EGFR Signaling Attenuates Osteoarthritis Development Following Loading Injury in Mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  14. Article
  15. Article
  16. Machine Learning-Derived Acetabular Dysplasia and Cam Morphology Are Features of Severe Hip Osteoarthritis: Findings From UK Biobank.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  17. Review
  18. Genetics of osteoarthritis.Osteoarthritis and cartilage · 2022
    Review
  19. EGFR Signaling Is Required for Maintaining Adult Cartilage Homeostasis and Attenuating Osteoarthritis Progression.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  20. A humanOsteoarthritis and cartilage open · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Martha C Castaño-BetancourtDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Dan S EvansCalifornia Pacific Medical Center Research Institute, San Francisco, California, United States of America.
Yolande F M RamosDepartment of Medical Statistics and Bioinformatics, Section Molecular Epidemiology. Leiden University Medical Center, Leiden, The Netherlands.
Cindy G BoerDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-4809-0044
Sarah MetrustryDepartment of Twins Research and Genetic Epidemiology Unit, King's College London, London, United Kingdom.
Youfang LiuThurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Wouter den HollanderDepartment of Medical Statistics and Bioinformatics, Section Molecular Epidemiology. Leiden University Medical Center, Leiden, The Netherlands.
Jeroen van RooijDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9754-073X
Virginia B KrausDuke Molecular Physiology Institute and Division of Rheumatology. Duke University School of Medicine, Durham, North Carolina, United States of America.
Michelle S YauDepartments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Braxton D MitchellDepartments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Kenneth MuirHealth Sciences Research Institute, University of Warwick, Warwick, United Kingdom.
Albert HofmanDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Michael DohertySchool of Medicine, University of Nottingham, Nottingham, United Kingdom.
Sally DohertySchool of Medicine, University of Nottingham, Nottingham, United Kingdom.
Weiya ZhangSchool of Medicine, University of Nottingham, Nottingham, United Kingdom.
Robert KraaijDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Fernando RivadeneiraDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Elizabeth Barrett-ConnorEpidemiology Division, Family Medicine and Public Health Department, University of California, San Diego, La Jolla, California.
Rose A MaciewiczRespiratory, Inflammation, Autoimmunity Innovative Medicines, AstraZeneca AB, Mölndal, Sweden.
Nigel ArdenNuffield Department of Orthopaedics, Rheumatology and musculoskeletal sciences, University of Oxford, United Kingdom.
Rob G H H NelissenDepartment of Orthopaedics, Leiden University Medical Center, Leiden The Netherlands.
Margreet KloppenburgDepartment of Rheumatology and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Joanne M JordanThurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Michael C NevittUniversity of California at San Francisco, San Francisco, California.
Eline P SlagboomDepartment of Medical Statistics and Bioinformatics, Section Molecular Epidemiology. Leiden University Medical Center, Leiden, The Netherlands.
Deborah J HartDepartment of Twins Research and Genetic Epidemiology Unit, King's College London, London, United Kingdom.
Floris LafeberUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Unnur StyrkarsdottirDecode Genetics, Reykjavik, Iceland.
Eleftheria ZegginiWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Evangelos EvangelouDepartment of Hygiene & Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Tim D SpectorDepartment of Twins Research and Genetic Epidemiology Unit, King's College London, London, United Kingdom.
Andre G UitterlindenDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Nancy E LaneUniversity of California at San Francisco, San Francisco, California.
Ingrid MeulenbeltDepartment of Medical Statistics and Bioinformatics, Section Molecular Epidemiology. Leiden University Medical Center, Leiden, The Netherlands.
Ana M ValdesSchool of Medicine, University of Nottingham, Nottingham, United Kingdom.
Joyce B J van MeursDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Funding

Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
Study of Osteoporotic FracturesR01AG005407 · NIA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI CUMMINGS, STEVEN RON, YAFFE, KRISTINE · 1986 to 2016
$23.2M
Osteoporotic Fractures in Men (MrOS) - San Francisco Coordinating CenterU01AR066160 · NIAMS · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI CUMMINGS, STEVEN RON · 2013 to 2017
$9.3M
Translational Researchin Aging Trainnig ProgramT32AG023480 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI LIPSITZ, LEWIS · 2004 to 2024
$7.6M
Study of Osteoporotic FracturesR01AG005394 · NIA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ENSRUD, KRISTINE · 1986 to 2015
$6.1M
Project 3P60AR049465 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JORDAN, JOANNE M. · 2003 to 2008
$6.0M
GWAS in MrOS and SOFRC2AR058973 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2009 to 2010
$5.7M
Integrative Resource to Develop Translational Strategies to Promote LongevityU24AG051129 · NIA · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI CUMMINGS, STEVEN RON, EVANS, DANIEL SPENCER · 2015 to 2019
$5.3M
Osteoporotic Fractures in Men (MrOS) - MinneapolisU01AG042145 · NIA · UNIVERSITY OF MINNESOTA · PI ENSRUD, KRISTINE · 2013 to 2019
$5.3M
Osteporotic Fractures in Men (MrOS)- Admin CenterU01AG027810 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2017
$5.1M
STUDY OF OSTEOPOROTIC FRACTURES: VERTEBRAL FRACTURESR01AR035583 · NIAMS · KAISER FOUNDATION RESEARCH INSTITUTE · PI HILLIER, TERESA A · 1986 to 2005
$3.2M
Osteoporotic Fractures in Men (MrOS) - PortlandU01AG042124 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2013 to 2019
$3.0M
NCATS NIH HHS UL1 TR000128NIAMS NIH HHS K24 AR048841NIAMS NIH HHS P60 AR030701NIAMS NIH HHS P60 AR049465NIAMS NIH HHS R01 AR035582NIAMS NIH HHS R01 AR035583NIAMS NIH HHS R01 AR035584NIAMS NIH HHS R01 AR051124NIAMS NIH HHS R01 AR052000NIAMS NIH HHS RC2 AR058973NIAMS NIH HHS U01 AR066160NIA NIH HHS R01 AG005394NIA NIH HHS R01 AG005407NIA NIH HHS R01 AG027574NIA NIH HHS R01 AG027576NIA NIH HHS T32 AG023480NIA NIH HHS U01 AG027810NIA NIH HHS U01 AG042124NIA NIH HHS U01 AG042139NIA NIH HHS U01 AG042140NIA NIH HHS U01 AG042143NIA NIH HHS U01 AG042145NIA NIH HHS U01 AG042168NIA NIH HHS U24 AG051129Wellcome Trust
6 · The paper itself

Abstract

Osteoarthritis is one of the most frequent and disabling diseases of the elderly. Only few genetic variants have been identified for osteoarthritis, which is partly due to large phenotype heterogeneity. To reduce heterogeneity, we here examined cartilage thickness, one of the structural components of joint health. We conducted a genome-wide association study of minimal joint space width (mJSW), a proxy for cartilage thickness, in a discovery set of 13,013 participants from five different cohorts and replication in 8,227 individuals from seven independent cohorts. We identified five genome-wide significant (GWS, P≤5·0×10-8) SNPs annotated to four distinct loci. In addition, we found two additional loci that were significantly replicated, but results of combined meta-analysis fell just below the genome wide significance threshold. The four novel associated genetic loci were located in/near TGFA (rs2862851), PIK3R1 (rs10471753), SLBP/FGFR3 (rs2236995), and TREH/DDX6 (rs496547), while the other two (DOT1L and SUPT3H/RUNX2) were previously identified. A systematic prioritization for underlying causal genes was performed using diverse lines of evidence. Exome sequencing data (n = 2,050 individuals) indicated that there were no rare exonic variants that could explain the identified associations. In addition, TGFA, FGFR3 and PIK3R1 were differentially expressed in OA cartilage lesions versus non-lesioned cartilage in the same individuals. In conclusion, we identified four novel loci (TGFA, PIK3R1, FGFR3 and TREH) and confirmed two loci known to be associated with cartilage thickness.The identified associations were not caused by rare exonic variants. This is the first report linking TGFA to human OA, which may serve as a new target for future therapies.

Indexed as

AgedAged, 80 and overCartilageClass Ia Phosphatidylinositol 3-KinaseFemaleGenetic HeterogeneityGenetic Predisposition to DiseaseGenome-Wide Association StudyHip JointHumansMaleMiddle AgedOsteoarthritis, HipPhosphatidylinositol 3-KinasesPolymorphism, Single NucleotideReceptor, Fibroblast Growth Factor, Type 3Class Ia Phosphatidylinositol 3-KinaseFGFR3 protein, humanPhosphatidylinositol 3-KinasesPIK3R1 protein, humanReceptor, Fibroblast Growth Factor, Type 3TGFA protein, humanTransforming Growth Factor alphaTrehalase

Identifiers

PMID27701424
PMCPMC5049763

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.